As of 2025-07-09, the Intrinsic Value of Woojung Bio Inc (215380.KQ) is 2,088.20 KRW. This 215380.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 1,793.00 KRW, the upside of Woojung Bio Inc is 16.50%.
The range of the Intrinsic Value is (631.83) - 133,270.48 KRW
Based on its market price of 1,793.00 KRW and our intrinsic valuation, Woojung Bio Inc (215380.KQ) is undervalued by 16.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (1,970.02) - 43,269.45 | (1,033.92) | -157.7% |
| DCF (Growth 10y) | (631.83) - 133,270.48 | 2,088.20 | 16.5% |
| DCF (EBITDA 5y) | 5,684.97 - 13,149.63 | 9,220.43 | 414.2% |
| DCF (EBITDA 10y) | 5,318.59 - 20,579.33 | 11,277.21 | 529.0% |
| Fair Value | -74.13 - -74.13 | -74.13 | -104.13% |
| P/E | (380.71) - 1,718.62 | 579.38 | -67.7% |
| EV/EBITDA | 1,279.60 - 11,061.08 | 5,018.88 | 179.9% |
| EPV | (6,734.51) - (15,942.29) | (11,338.38) | -732.4% |
| DDM - Stable | (161.71) - (562.75) | (362.23) | -120.2% |
| DDM - Multi | 2,823.51 - 7,974.47 | 4,211.19 | 134.9% |
| Market Cap (mil) | 30,176.19 |
| Beta | 1.21 |
| Outstanding shares (mil) | 16.83 |
| Enterprise Value (mil) | 77,253.99 |
| Market risk premium | 5.82% |
| Cost of Equity | 7.97% |
| Cost of Debt | 13.54% |
| WACC | 9.56% |